Fairchem Organics Ltd · NSE:FAIRCHEMOR

Fairchem Organics — Q2 FY2025 Earnings Presentation

16 slides from Fairchem Organics's earnings presentation, Nov 13, 2024

  1. Slide 1: Cover letter to stock exchanges

    FAIRCHEM ORGANICS LIMITED Regd. Office & Works: 253/P and 312, Village – Chekhala, Sanand – Kadi Highway, Taluka: Sanand, District: Ahmedabad – 382 115, GUJARAT, INDIA Phone (Board Nos.): (02717) 687900, 687901, +91 90163 24095 E-mail : cs@fairchem.in CIN: L24200GJ2019PLC129759 website: www.fairchem

  2. Slide 2: Earnings Presentation Q2/H1-FY25

    Earnings Presentation Q2/H1-FY25

  3. Slide 3: Company at a Glance

    Company at a Glance Well entrenched Customer Forward integration to Relationships in high make value added products growth industries like from co-product – Paint, Inks, Printing, Monomer (Monobasic) Long lasting Pan India Promoted by Fairfax Fatty Acid – stream to lubricants, Cosmetics India Holdin

  4. Slide 4: Company Overview

    Company Overview • Fairchem Organics Ltd. (Fairchem) is engaged in the business of manufacturing of Oleo Chemicals and Nutraceuticals, since the last 28 years. Revenue & EBITDA Margin (In Mn) • It has a state -of-the-art Manufacturing unit which was set up in 1995 and has over the years 6,432 6,480

  5. Slide 5: Fairchem's Competitive Advantage

    Fairchem’s Competitive Advantage Major Player in the Indian Oleo Chemical Market Using Renewable Resources • Processing waste from edible oil refining process to produce high value oleo chemicals giving it price advantage • Enjoy Leadership Position in the industry due to barriers to entry • Focus o

  6. Slide 6: ESG Initiatives

    ESG Initiatives ENVIRONMENT SOCIAL GOVERNANCE Effluent Method of Disposal CSR Activities • Always be adequately capitalized • Contribution towards ‘Project Dialysis” of Zero Liquid Discharge by Multi around INR 9.2 Mn • Not overleverage the balance sheet Water Effect Evaporator and Agitated Discharg

  7. Slide 7: Q2/H1-FY25 Performance

    9) EAR GENS Q2/H1-FY25 Performance

  8. Slide 8: Q2/H1-FY25 Financial & Operational Highlights

    Q2/H1-FY25 Financial & Operational Highlights Q2-FY25 Financial Performance • Sales of finished goods declined by 15.60% and 15.90% respectively in terms of volume and value, on a QoQ basis. INR 1,386 Mn INR 87 Mn 6.28% • Demand for our Linoleic Acid/Soya Fatty Acid from the Revenue from EBITDA Marg

  9. Slide 9: Quarterly Financial Performance

    Quarterly Financial Performance PARTICULARS (INR Mn) Q2-FY25 Q2-FY24 Y-O-Y Q1-FY25 Q-O-Q Revenue from Operations 1,386 1,522 (8.9)% 1,649 (15.9)% Total Expenses 1,299 1,354 (4.1)% 1,431 (9.2)% EBITDA 87 168 (48.2)% 218 (60.1)% EBITDA Margins (%) 6.28% 11.04% (476) Bps 13.22% (694) Bps Other Income 4

  10. Slide 10: YTD Financial Performance

    YTD Financial Performance PARTICULARS (INR Mn) H1-FY25 H1-FY24 Y-O-Y Revenue from Operations 3,035 3,128 (3.0)% Total Expenses 2,730 2,843 (4.0)% EBITDA 305 285 7.0% EBITDA Margins (%) 10.05% 9.11% 94 Bps Other Income 6 6 - Depreciation 52 43 20.9% Finance Cost 18 27 (33.3)% PBT 241 221 9.0% Tax 62

  11. Slide 11: Historical Income Statement

    Historical Income Statement PARTICULARS (INR Mn) FY22 FY23 FY24 H1-FY25 Revenue from Operations 6,432 6,480 6,215 3,035 Total Expenses 5,383 5,756 5,545 2,730 EBITDA 1,049 724 670 305 EBITDA Margins (%) 16.31% 11.17% 10.78% 10.05% Other Income 3 7 11 6 Depreciation 71 82 93 52 Finance Cost 69 63 42

  12. Slide 12: Historical Balance Sheet

    Historical Balance Sheet ASSETS FY23 FY24 H1-FY25 EQUITY AND LIABILITIES FY23 FY24 H1-FY25 EQUITY Non-Current Assets Equity Share Capital 130 130 130 Property, Plant and Equipment 1,514 1,868 1,866 Instruments entirely equity in nature Capital work-in-progress 349 60 148 Other Equity 2,462 2,769 2,8

  13. Slide 13: Historical Cash Flow Statement

    Historical Cash Flow Statement PARTICULARS (INR Mn) FY23 FY24 H1-FY25 Cash and Cash Equivalents at Beginning of the year 0.1 0.1 0.1 Cash Flow From Operating Activities 496 745 (107) Cash Flow from Investing Activities (145) (176) (147) Cash Flow From Financing Activities (351) (569) 254 Net Inc./(D

  14. Slide 14: Key Financial Highlights

    Key Financial Highlights Revenue (In Mn) EBITDA (In Mn) & EBITDA Margin (%) PAT (In Mn) & PAT Margin (%) 5 Year CAGR - 20% 5 Year CAGR - 13% 5 Year CAGR - 14% 6,432 6,480 6,215 1,049 679 724 687 670 435 405 3,966 425 3,065 3,035 484 347 15.79% 17.32% 16.31% 305 179 11.32% 10.72% 10.56% 11.17% 10.78%

  15. Slide 15: Capital Market Data

    Capital Market Data Stock Market Performance (As on 30th September, 2024) Dividend Percentage 40% 130.00% 30% 20% 75.00% 75.00% 10% 0% 35.00% -10% 25.00% 15.00% -20% Oct-23 Nov-23 Dec-23 Jan-24 Feb-24 Mar-24 Apr-24 May-24 Jun-24 Jul-24 Aug-24 Sep-24 Fairchem Organics Sensex FY19 FY20 FY21 FY22 FY23

  16. Slide 16: Disclaimer

    Disclaimer Fairchem Organics Limited Disclaimer: The information contained in this presentation is only current as of its date. All actions and statements made herein or otherwise shall be subject to the applicable laws and regulations as amended from time to time. There is no representation that al

Fairchem Organics — Q2 FY2025 Earnings Presentation on 6ix